Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

Get caught up with the latest news from the 2026 Healthcare Information and Management Systems Society (HIMSS) Global Health ...

Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced a strategic partnership with NDS Corporation (NDS ...

Sky Labs announced on 12th that it is supporting the Established Investigator Award for Clinical Hypertension' developed by ...

A burdensome regulatory environment is pushing clinical trials overseas. Jacob Becraft is the co-founder and CEO of Strand Therapeutics.

Pharmaceutical companies in India are driving innovation, biosimilars, APIs & global exports while strengthening research, manufacturing & healthcare access.

Explore pharmaceutical companies to know 2026 delivering innovative pharmacy solutions and improving patient care across the U.S.

Midtown-based Dianthus Therapeutics announced a $625 million public offering this week to raise capital for anti-inflammatory drug development. The company, which specializes in treatments for ...

If you are fried from constant fires at work but still need a real income, you are not alone. And there are careers that ...

GH Research PLC is rated a Buy with $280.7M in cash, supporting lead candidate GH001 for Treatment-Resistant Depression. Read more on GHRS stock here.

CoRegen's therapies are developed from the research by the late Dr. Bert O'Malley of Baylor College of Medicine. The ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...